Conférences - Pharmacologie et développement des médicaments

Chemical biology is a scientific discipline that promises to apply the latest chemical approaches to interrogate complex biological systems and is, consequently, at the very heart of modern pharmacology. This conference will explore how recent advances in chemical biology are helping to expand the druggable proteome and enhance our understanding of disease biology .

EMBL Events;     Tél.: [+49 6221 387 8797];     Email.: events@embl.de

Drug discovery, chemical biology, genomics, DNA-sensing pathways, proteolysis targeting chimeras (PROTACs), targeted protein degradation, druggable proteome, druggable genome, phenotypic screens, chemical probes, chemogenomics, bioinformatics

Oxford Global

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Biomarkers, Precision Medicine, Drug Development, Bioinformatics, Genomic Markers

SMi Group

SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field. For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.

Tél.: [02078276000];     Email.: ssapal@smi-online.co.uk

Organ-on-chips, microfluidics, cell culture, 3D cell culture, 3D bioprinting, bioprinting, organoid, extracellular matrix, ECM, tissue engineering, physiochemical factors, cell-based assay, cytotoxicity, cell metabolic pathways, cancer research, molecular diagnostics, cell and gene therapy, microphysiological, co-culture systems complex in-vitro models, high throughput screening, 3D imaging, drug screening, extracellular matrix scaffolds, 3D drug development, regenerative therapies

Cellules souches,    Législation en médecine et pharmacologie

BDG Lifesciences, India

In Bangkok, we have launched our 4th event which is a 1-Day Technical & Hands-on Workshop on Molecular Modelling in which we will cover Virtual Screening, Molecular Docking & Predictive Toxicology topics in Drug Design.

Workshops Coordinator;     Tél.: [+917017955472];     Email.: workshops@biodiscoverygroup.com

drugdiscovery, bioinformatics, bioinfo, itsdifferentbybiodiscovery, bdglifesciences, biotech, biotechnology, proteomics, molecular docking, admet, bkk, bangkoktravel, bangkokdiaries, thailanddiaries, thailandtravel, bioinformaticsasia, bangkokstudents, thaistudent

King Abdullah International Medical Research Center (KAIMRC)

2nd Therapeutics Discovery From Bench to Fist in Human Trials conference provides a unique opportunity for experts around the world to come together, learn and discuss the latest research update on drug discovery and development. It is a unique in its kind to be hosted in the newly opened research facility at King Abdullah International Medical Research Center (KAIMRC) that is aimed to boost the academic drug discovery and development research (DDDR) in the Kingdom of Saudi Arabia and link it with the international recognized body in the field.

Email.: KAIMRC-Therapeutics@ngha.med.sa

Themes that will be discussed in two days and each will include Keynote presentations, selected abstract presentation and panel discussions. Academic Drug Discovery Platforms, Rare Diseases Targets and Orphan Drugs Discovery, Artificial Intelligence in Drug Discovery, Anti-Infective Drug Discovery in the Era of Bad Bugs, Natural Products as source of novel drug.

Virtue Insight

21st Pharmacovigilance 2020 event keeps an immersed eye on discussion of critical topics in PV domain, which capture influence of emerging technologies like AI, IoT, Big Data. Not merely that, we have exciting surprise activities which will help you to interact more with your peers. This will be surely an exciting event wherein you could get chance to meet big industry gems. Let’s gather to shape the industry with your magnificent ideas.

Email.: kavitha@virtueinsight.co.in

Pharmacovigilance, regulatory affairs, Drug Safety, Drug Development, patient safety, RiskManagement, Pharmaceuticals, healthcare

Virtue Insight

8th Annual Pharma AntiCounterfeiting & Serialisation 2020 will provide you insight into the current state of play in the EU & US on the vital role of technology impact in the sustainability of pharma and healthcare systems. Our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. The event will also address some of the most achievable possibilities of integrating AI, IoT and blockchain within pharma and healthcare through a mixture of practical, lectures and roundtable discussions specifically designed.

Email.: kavitha@virtueinsight.co.in

Anticounterfeiting, Serialisation, Pharmaceuticals, Counterfeit, Supply Chain, Track Trace, Drug regulatory, Packaging, labeling, Blockchain, ArtificialIntelligence, IoT

Virtue Insight

Our 3rd Annual Pharma AI, IoT & Blockchain 2020 will provide you insight into the current state of play in the EU & US on the vital role of technology impact in the sustainability of pharma and healthcare systems. Our speakers will outline the key recent developments in technology impact in pharma and healthcare in the EU and other international jurisdictions. The event will also address some of the most achievable possibilities of integrating AI, IoT and blockchain within pharma and healthcare through a mixture of practical, lectures and roundtable discussions specifically designed.

Email.: kavitha@virtueinsight.co.in

Blockchain, Artificial Intelligence, IoT, AI, interntet of things, pharma, healthcare, BigData, Drug Discovery, Pharmaceuticals

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The ECI “Delivery of Nucleic Acid Therapeutics: Biology, Engineering and Development” conference will provide a forum for increasing our mechanistic understanding of the biological processes underpinning non-viral and viral delivery, including molecular and cellular biology, virology, in vivo pharmacology and toxicology, rational optimization strategies, targeting, formulation, bioengineering and process development solutions to scale-up and manufacturing, regulatory considerations and preclinical and clinical NAT programs.

Tél.: [212516760];     Email.: noel@engconfintl.org

nucleic acid RNA mRNA viral drug development vectors tropism virology NAT cargo ASO's Therapeutics

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Join us at our 3rd Annual Formulation & Drug Delivery USA Congress - Over 300 delegates - Over 55 case studies & Presentations - Six highly interactive streams

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Formulation, Drug Delivery, Drug Development, Cell & Gene Therapy

Oxford Global

Tél.: [+441865248455];     Email.: e.hawkings@oxfordglobal.co.uk

Respiratory, Drug Delivery, Inhalation, Pharmaceutical

In the light of this theme “Future breakthrough in Toxicology and Pharmacology for the better world”, Toxicology and Pharmacology Summit aims to provide a forum for international researchers and academicians from various areas of biology, chemistry, pharmacology, and medicine by providing one kind of platform for critical analysis of new designing, and to share latest cutting-edge research findings, most recent movements and latest upgrades inside the field of Pharmacology with explicit keynote lectures, plenary sessions, Poster competition, Young Researchers’ Forum (YRF), Workshops, Symposiums and Exhibitions from elite researchers, distinguished scientists and business delegates. It allows delegates to have issues addressed on Toxicology & Pharmacology by recognized global experts who are up to date with the latest developments in the field to a common forum and also exchange ideas makes us updated about the advancements and innovations in Toxicology and Pharmacology in a wide range.

Tél.: [1 631 303 3007];     Email.: toxicology.us@gmail.com

Medicine Development and Safety Testing, Therapeutic Drug Monitoring and Drug, Environmental and Occupational Toxicology, Developmental Pharmacology, Molecular and Biochemical Toxicology, Reproductive and Developmental Toxicology, Applied Pharmacology, Genetic Toxicology and Toxicity Testing, Product Development Toxicology, Industrial & Occupational Toxicology, Toxicological Pharmacovigilance, Toxicologic Pathology, Clinical Trials on different Diseases and Medical Devices, Toxicology Consulting, Genetic and Cellular Toxicology, Aquatic Toxicology, Toxicology Global Market, Toxicology Current Advances, Pharmacology and Drug Design, Pharmacological Testing, Toxicology Risk Assessment, Immunopharmacology and Immunotoxicology, Advances in Pharmacological Research, Market Analysis of Pharmacology, Biochemical pharmacology, Cardiovascular Pharmacology.

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Cambridge Healthtech Institute

The fastest growing bioprocessing meeting in Europe is returning in 2020, this time in Barcelona with more ground-breaking science, technologies and exhibitors than ever before! The 8 track conference, which doubled in attendance in 2019, brings together leading bioprocessing scientists to discuss the latest developments and trends in cell culture, cell line, protein expression, recovery, purification, cell and gene therapy manufacturing, and new for 2020, analytical characterisation, formulation and aggregates.

Cambridge Healthtech Institute;     Tél.: [7819725400];     Email.: chi@healthtech.com

cell culture, cell line, protein expression, recovery, purification, cell and gene therapy manufacturing, analytical characterisation, formulation, aggregates

The rising tide of counterfeit medicines are turning into a serious concern around the world, and have progressively been showing up through the real pharmaceutical supply chain, including community and online drug stores.Counterfeit drugs are not only a global public health risk, but also harm the quality of the product, the integrity of the brand, the economy and even national security.We require both countrywide and industry-level participation, and in addition public and private sector coordinated effort, to identify and definitively battle counterfeiters.

Tél.: [02070960786];     Email.: info@corvusglobalevents.com

PharmaSecurityWorld, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecuritySerialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

SMi Group

As one of the most impactful pharmaceuticals for maintaining public health, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal, including colistin, carbapenems, 3rd and 4th generation cephalosporins, useless. This year’s event aims to showcase a suite of sessions focused on novel drugs and approaches, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR. It is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020, along with leaders from the pharmaceutical industry, academia, regulatory and funding bodies, and public-private partnerships to discuss the way forward.

Tél.: [02078276000];     Email.: events@smi-online.co.uk

Resistance; superbugs; superdrugs; mrsa; infectious diseases; investment; smart materials, infection, drug discovery, antibacterial, antimicrobial, anti-infective, multidrug resistance, MDR, diagnostics, immunization, inhibitors, antibiotic, resistance, antibiotic resistance, vaccine, bacterial, infections, drive a-b, genome sequencing, multi-resistant gram-negative, BARDA, Microbiota, EBOLA, bacteria, biotech, biomedical, pem, disease, amr, ppp, health, containment, microbiology, hepatitis, hcv, clinical, lab, gram positive, gram negative, fungi, fungal, population, contamination, viral, virus, amr, zika, fda, pathogen

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Corvus Global Events

The Annual Pharma Supply Chain and Security World Summit is back in London for the 3rd time, and this time with more focus on optimizing your supply chain challenges to ensure an agile, responsive, streamlined and secured supply chain. Pharmaceutical companies have to resist the challenges looming from supply chain security lapses to avoid infiltration of counterfeit, diverted, and adulterated drugs entering into the supply chain. To protect your brand and build a genuine future, Corvus Global Events invites you to Pharma Supply Chain & Security World 2020 - Supply-chain, Drug Serialization And Anti-Counterfeiting conference, which will have Pharma industry experts sharing various challenges faced, new strategies, case studies and use of innovative ideas, the conference will also offer opportunities to encourage partnerships and collaborations. In this conference you’ll not only discover innovative technologies, transformation strategies and collaboration methods, but how best to implement them to optimise your supply chain processes and strategies for drug anti-counterfeiting.

Corvus Global Events;     Tél.: [+442070960786];     Email.: info@corvusglobalevents.com

PharmaSecurityWorld, SupplyChain, counterfeitdrugs, Anticounterfeiting, BrandProtection, drugsecurity Serialization, Traceability, SupplyChain, IP, PharmaSupplyChain, Packaging, BrandEnforcement, BrandIntegrity, Labelling, Printing, TrackAndTrace, DrugRegulatory, RFID, fakedrugs

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

ITOC7 is organised by the WMA GmbH in scientific cooperation with the ITOC Association, the Tumor Centre in Munich (TZM), the Society for Immunotherapy of Cancer (SITC), the German Cancer Consortium (DKTK) as well as the Comprehensive Cancer Center Munic

The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from April 2 – 4, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early clinical translation and to address its unique challenges. The main goal of the series of ITOC conferences is to provide a unique platform for discussions where all those dedicated to the immunotherapy of cancer can exchange their knowledge and latest findings to advance the oncology drug development and delivery.

WMA GmbH Congress Office;     Tél.: [+431405138318];     Email.: itoc@medacad.org

Emerging concepts / novel agents Microbiome and immune system/immunotherapy Tumor microenvironment Vaccine Therapy Precision Medicine Meets Immunotherapy (Immuno-Monitoring) Cell Therapy in Solid Tumors Cell Therapy in Haematologic Diseases Combination Therapy

Cancérologie,    Immunologie et Allergie

BDG Lifesciences, India

We are glad to announce our 8th event in DUBAI which is a 1-Day Technical & Hands-on Workshop on Molecular Modelling in which we will cover Virtual Screening, Molecular Docking & Predictive Toxicology topics in Drug Design.

Workshops Coordinator;     Tél.: [+917017955472];     Email.: workshops@biodiscoverygroup.com

drugdiscovery, bioinformatics, bioinfo, itsdifferentbybiodiscovery, bdglifesciences, biotech, biotechnology, proteomics, dubai, uae, sharjah, abu dhabi, dubaidiaries, travelmiddleeast, gulf dubiotech

Cambridge Healthtech Institute

Cambridge Healthtech Institute's 15th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, Drug Discovery Chemistry provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent conferences. The 2020 event includes new coverage of RNA as a small molecule target, expanded coverage of artificial intelligence for early drug discovery, plus even more short courses to choose from.

Marketing Manager;     Email.: asaenger@healthtech.com

drug discovery, small molecules, therapeutics, medicinal chemistry

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Oxford Global

Tél.: [+441865248455];     Email.: e.hawkings@oxfordglobal.co.uk

Pharmaceutical, Drug Development, Formulation, Drug Delivery

Oxford Global

Meet and learn from experts in the biopharmaceutical manufacturing community to address critical strategic developments and technical innovation in continuous manufacturing & CMC, upstream & downstream process development and the manufacture of advanced therapeutics.

Tél.: [+441865248455];     Email.: e.hawkings@oxfordglobal.co.uk

Biomanufacturing, Upstream Bioprocessing, Downstream Bioprocessing, Biologics Manufacturing, Cell & Gene Therapy Manufacturing, Smart Factories, Digitalisation, CMC, Continuous Manufacturing

Alzheimer's Drug Discovery Foundation

This interactive workshop is designed as an introductory course covering all aspects of drug discovery for neurodegenerative diseases, including Alzheimer’s, Parkinson’s, Huntington’s disease, Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration, Multiple Sclerosis, ALS, FTD, MS. This unique workshop offers great opportunities to connect with key stakeholders from pharmaceutical, biotechnology, government and academic sectors. ADDF encourages young investigators, researchers from academia, bio-pharmaceutical and start-up organizations to submit their work for poster presentation. Application is open online through January 31, 2020. ADDF invites applications for the Young Investigator Travel Scholarships.

Event Secretariat;     Tél.: [224-938-9523];     Email.: meetings@alzdiscovery.org

drug discovery, neurodegeneration, Alzheimer's, Parkinson's, Huntington's disease, Amyotrophic Lateral Sclerosis, Frontotemporal Degeneration, Multiple Sclerosis

Oxford Global

Over 150 attendees working in peptides and oligonucleotides, representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions. Over 40 case studies, presentations and panel discussions focused on the key issues in peptide technologies, therapeutics case studies, discovery & development of oligonucleotide therapeutics, manufacturing and process development.

Tél.: [+441865248455];     Email.: b.copeman@oxfordglobal.co.uk

Peptide, Oligonucleotide, Peptide Chemistry, Peptide Characterisation, Peptide Purification, Peptide Discovery, Peptide Research, Antimicrobial Peptides, Peptide Synthesis, Peptide Manufacturing, Peptide Bioavailability, Peptide Toxicity, Peptide Process Development, Peptide Therapeutics, Peptide, Immunogenicity, Peptide Immunology, Peptide Stability, Peptide Automation, Peptide Half Life Extension, Peptide Novel Diseases, Peptide Endocrinology, Peptide Infectious Diseases, Peptide Oncology

Epigenetics is a field that impinges on many biological processes since it encompasses fundamental mechanisms of gene regulation. In addition, this area is currently exploited for drug development, particularly against cancer, since epigenetics regulators are miss-regulated in this disease. The conference will bring together all these themes. It will provide a comprehensive backdrop to the basic principles behind Epigenetic and cross-reference to their relevance to disease. There will be sessions on Chromatin, RNA and DNA regulatory pathways and a separate session on recent developments in drug discovery from Pharma.

Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com

Epigenetics, Cancer, Chromatin regulatory pathways, RNA modification pathways, DNA modification pathways, Drug discovery

Génomique et bio-informatique,    Cancérologie

Engineering Conferences International (ECI)

It is well known that the physical and chemical properties of the DS (API) have major impacts on the formulation and the Drug Product (DP) process. In any dosage form including solid, liquid and semi-solid, the Drug Substance (DS) or Active Pharmaceutical Ingredient (API) goes through a formulation process. This process to make the final drug product serves many purposes, but all with the goal of eventually delivering the active ingredient to the desired sites in the patients’ body in the most convenient way and to achieve optimal therapeutic effect.

Tél.: [2125146760];     Email.: noel@engconfintl.org

Role particle engineering process scaleup Pharmaceutical composite materials DS/DP interface integration DS (API)

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Oxford Global

The events are aimed at VPs and senior directors of discovery in biology and chemistry from global pharmaceutical and biotech organisations. New for 2020, the event features focused R&D leaders sessions on Drug discovery Modalities and AI in drug development. It will also highlights successful strategies in delivering On Target Discovery, Phenotypic/Crispr Screening, Applications Of Organ-In-A Chip Platforms As Well As Tissue And 3D Culture For Disease Modelling. Empowering Drug Discovery with Chemical Biology, senior experts will also learn about enabling technologies that facilitate quicker drug development timelines such as protein degradation tools, target-based discovery techniques including RNA as novel targets. Do not miss out on cutting edge insights into computational chemistry and drug design methods.

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Drug Discovery, Drug Design, Medicinal Chemistry

Médecine translationnelle, essais cliniques,    Biochimie et chimie médicale, toxicologie

Oxford Global

Oxford Global is proud to present our 2nd Annual Neuroscience Drug Discovery Congress, taking place 26 – 27 May 2020 in Berlin, Germany, which will bring together key leaders and influencers from global pharmaceutical organisations and leading academic research institutions. Discover the latest developments and critical approaches in neuroscience discovery, alongside cutting-edge enabling tools and technologies for developing neurological treatments. The congress encompasses the emerging trends and technological breakthroughs in drug discovery for neurodegenerative diseases, together with presentations on advancements in stem cell technologies to fuel drug discovery and iPS cells in disease modelling. On Day 2, we aim to emphasise the importance of targeted therapeutics and the crucial roles of biomarker development and gene therapy in drug discovery and translational neuroscience.

Key speakers include:

• Emilio Merlo Pich, Executive Director Neurology & Quantitative Medicine Neuroscience Therapeutic Area, Takeda

• Andreas Hartmann, Executive Director PreClinical Safety, Therapeutic Area Head, Novartis

• Ross Jeggo, Head of Research, Neuropsychiatry Centre for Therapeutic Innovation, Servier

View the Agenda: https://bit.ly/2rYH2kT

With over 20 unmissable presentations, the two-day congress offers an intuitive platform for high level scientific and business discussions, ensuring valuable networking and interactive sessions.

This events form part of the R&D Series EU and are co-located with our 21st Annual Drug Discovery Summit and 8th Annual Drug Design & Medicinal Chemistry Congress

For more information contact g.alonso@oxfordglobal.co.uk or visit the website: https://bit.ly/2PfND2z

Go Social: Join our Drug Discovery & Development Network on LinkedIn, follow us on Twitter @drugdiscovery1 and & join the conversation at #RNDSeries20

LIVE WEBINAR:

Predictive Model Approaches For Pharmacokinetics And Pharmacodynamics In CNS Discovery

Hosted by Elizabeth de Lange, Professor in Predictive Pharmacology, LACDR, Leiden University

Register (free): https://bit.ly/2RQHjBg

Tél.: [+441865248455];     Email.: g.alonso@oxfordglobal.co.uk

Neuroscience, Drug Discovery, Drug Development, Drug Design, Medicinal Chemistry

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Informa Markets In India

Launched in 2012, InnoPack Pharma Confex has been a premier platform for Pharmaceutical, Biopharmaceuticals & Healthcare packaging; drug delivery; machinery and medical devices. It has been successfully helping the industry to congregate, network, exchange ideas and knowledge, form alliances and shape the future of the industry, all under one roof.

The 2019 edition witnessed 55+ exhibiting companies and 900+ attendees from different regions. The Confex ensured the continuous engagement of the audience, speakers and exhibitors through various networking activities, workshop, round table discussion and an awards night dedicated to celebrate the Indian Pharma Packaging Industry.

The 2020 edition promises to benefit the attendees through its multiple opportunities focusing on developing valuable partnerships. This year the confex will witness the launch of new features like Solution Labs, Start-up Pavilion, Innovative Exhibitor Showcase, Technical Workshops, and a dedicated Scientific Conference which will ensure it caters to the entire value chain of the pharma packaging industry

Marketing Manager;     Tél.: [+91 98197 43776];     Email.: Meghna.Dekhtawala@ubm.com

Pharmaceutical, Packaging, Pharma, Manufacturing

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Virtue Insight

This conference will provide an overview of global pricing, market access systems and cost management techniques, as well as in-depth discussion of some of the most current trends and changes. This Conference will bring together top pharmaceutical, biotechnology and regulatory representatives under one roof that will address the key issues of the industry. It will be studied with the help of case studies and industry experiences.Following a raft of health policy reforms impacting pharmaceutical pricing in almost every major country in the EU.

Email.: kavitha@virtueinsight.co.in

outcomes research, health economics, government affairs, pharma, pricing, reimbursement, market access, marketing, payer, heor, evidence, hta

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

The French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT)

Interfacing Chemical Biology and Drug Discovery, Chemistry in living systems & Chemical biology for targets identification, Recent Advances in targeted Protein-Protein interactions including protein degradation and targeted protein-DNA/RNA interactions, Recent Trends in drug development for neurodegenerative diseases, Innovations in cancer therapeutics, Tackling new challenges in delivery systems and drug formulation, Case studies: moving new chemical entities to the market

This conference focuses on the design, synthesis and clinical validation of new drug delivery vehicles. This conference is designed to bridge the gap between basic science and unmet clinical needs.

Conference Manager;     Tél.: [00441638724137];     Email.: admin@fusion-conferences.com

Therapeutic gene editing, Extrahepatic delivery of nucleic acids, Characterization of therapeutic nanoparticles and control strategies for manufacturing, New linkers for triggered or controlled release, New long acting technologies, Tumor targeting with nanoparticles, recent progress and challenges

Pharmacogénétique, Médecine personnalisée,    Législation en médecine et pharmacologie

Tél.: [+31887569555];     Email.: congress2020@ecnp.eu

brain disorder, health, neurology, pharma, mental disorder

Neurologie,    Psychiatrie

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Biogate Scientific Center welcomes Vaccines Summit Ohio (VSOhio20) in Columbus, OH from October 05-07, 2020. VSOhio20 will cover a broad range of topics like animal models, clinical trials, big data, and analytics. The summit will bring together participants from around the globe, including high-level political decision-makers, health ministers, UN organizations, NGOs, academia representatives, renowned researchers and healthcare professionals, vaccine industry CEOs, celebrities and social media influencers who actively support vaccination.

Tél.: [+1 410 246 4289];     Email.: sachin@bsc.events

Vaccine Technology, Animal Models, Influenza Vaccines, Vaccine Safety Science, Regulatory Science, Clinical Evaluation, Nonclinical Development, Vaccine Hesitancy, Big data and Analytics

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Prepare for patent expiry with a winning LCM plan for established brands – Know which drivers of differentiation can be used – Learn where, when and how to compete in a generic world using late stage LCM strategies & tactics – Learn how to make portfolio management decisions for mature brands.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand what HTA really means, the different types of HTAs across the EU and what can be expected from it – Learn the optimal HTA process and which criteria for assessment should be applied – Discover multiple solutions for optimising the quality of the evidence.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to engage patients with multi-channel disease awareness / patient activation campaigns – Know how to support patients in their therapy with multi-stakeholder / multi-channel patient adherence programmes – Be able to measure success and impact on the critical success factors of a patient-centric organisation.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to analyse your brand’s market so that you discover all sales levers – Know how to determine priority segments and define a value positioning statement – Learn how to design the optimal mix of marketing tactics in both Red (highly competitive) & Blue (highly innovative) Ocean markets.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the marketing principles that determine a pharmaceutical’s commercial success - Learn how your function can contribute to a pharma brand’s success in the new environment - Know how pharma marketers take strategic and tactical decisions - Gain ideas for cross-functional synergies that benefit a brand’s success.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and practice in role plays the whole armamentarium of winning strategies, tools, dos & don’ts, tricks & tips in each step of the pharma licensing negotiation process: planning – internal negotiations – making the first contact – term sheet assumptions – face-to-face meetings – resolving issues – contract closure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn and anticipate the market access challenges in rare diseases – Know how to leverage patient-centric real world evidence to accelerate the patient and market access of innovative and potentially transformative Orphan Medicinal Products (OMPs) and Advanced Therapy Medicinal Products (ATMPs) – Acquire planning tools that maximise product value of OMPs and ATMPs from launch to loss of exclusivity.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the drivers of patient health behaviours – Learn how to identify and interpret specific individual drivers of health behaviours – Understand the practical steps to design/enhance your support solutions in a way that delivers true personalisation and support for all stakeholders - Take your current patient/caregiver/HCP support solution(s) to the next level with insights from Professor John Weinman and Nathan O’Donnell.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the valuation concepts and techniques that are commonly applied in the pharma and biotech world – Know how to assess and calculate the value of a biotech company – Learn how to calculate the value of a pharmaceutical in development and how to structure a licensing deal.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the role of MSLs within the organisation – Gain business acumen by understanding how the MSL can optimally add value to both external and internal stakeholders – Know how strategic decisions determine MSL tactics – Learn how to successfully plan and implement typical MSL tactics, and how to assess their impact – Discuss and discover how to deal with issues that MSLs typically are confronted with.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Be able to decide on the best deal type for products in R&D – Know what to include in CDAs, MTAs and term sheets – Learn how to prepare product information and how to find potential partners – Know how to calculate the value of your product and optimise the deal structure.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand Market Access and grasp the structure of a healthcare system with its stakeholders – Learn the Market Access environment in Europe’s major markets – Know how to develop a Market Access Plan and how to communicate value to stakeholders.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how medical affairs can enhance the commercial success of pharma brands with market insight generation, brand value definition, and HCP/patient engagement – Learn the critical success factors of a competitive medical affairs strategy and of an impactful tactical mix – Get familiar with the fundamentals of health economics and of leadership development.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the language, the concepts and research techniques in pharmaceutical pricing – Learn how to set prices for optimal access and returns across Market Access systems, payer types and at different times of a product’s life cycle – Grasp the impact of international reference pricing and parallel trade, and how to deal with these.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the terminology, tools, models and argumentation used in health economic evaluation articles – Learn to distinguish good from bad ones – Know how to integrate HECON studies into clinical & marketing plans – Learn how to use HECON evaluations towards healthcare payers.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn to design a digital innovation strategy for Medical Affairs – Grasp the full power and trends of the whole spectrum of digital tactics that affect physicians and patients – Learn how to optimise the mix of tactics and to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn how to design a digital marketing strategy for your brand, therapeutic area or company that integrates into the whole marketing mix – Grasp the full power and trends of all digital tactics in pharma – Learn how, and when, to select the appropriate tactics, optimise the mix and how to measure their business impact.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Understand the structure of the pharma business development process in the pharma-biotech world – Grasp the terminology, challenges, concepts & tools in each step, from analysis and planning... up to closing and following-up a deal – Be prepared for the financial and legal pitfalls.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Master the critical success factors of a commercial drug launch: Selecting the right launch type – A structured roadmap – The critical market insights you need to gain in pre-launch phases – Identifying leverage points along the patient journey – Defining and prioritising customer segments - Designing the most effective omni-channel strategy and plan.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com

Learn the evidence-based concepts, models and techniques that work best to forecast the sales of pharmaceuticals – Know how to build Market Access into your forecasts – Learn to distinguish reliable from bad forecasts and how to forecast cost-effectively – Get practice with an Excel-based forecasting tool that integrates all the techniques taught.

Tél.: [+3227090142];     Email.: annelies.swaan@celforpharma.com